We identified 32 studies that met our inclusion criteria. Results: We found that the relative risk of developing a depressive disorder was incidence rate ratio = 0.79 (95% confidence interval ...

The diagnosis of major depressive disorder is based on the patient's self-reported experiences, behavior reported by relatives or friends, and a mental status examination. There is no laboratory ...

Major depressive disorder (MDD) is a chronic and recurrent mental condition leading to huge impacts on direct and indirect personal and public medical costs. To overcome such a serious mental ...

Sleep problems may be one of the first symptoms of major depressive disorder -- a serious, but treatable mental health problem, more commonly known as depression. Not only a symptom of depression ...

Neumora Therapeutics to release phase 3 data on Navacaprant for MDD treatment in 2024. Check out NMRA's catalysts that might ...

Depression, sometimes called major depressive disorder, can hurt your ability to think through even simple daily tasks. Doctors call this decline in thinking skills "cognitive impairment." ...

White matter alterations within the brain are associated with cognitive impairment among individuals with and without major ...

Transcranial magnetic stimulation for alcohol use disorders is under investigation. Research to date suggests TMS could play ...

Nelivaptan (NB-415, SSR-149415) is under development for the treatment of depression including major depressive disorder (MDD). The drug candidate targets vasopressin receptor 1B ( (V1bR). It is ...

From 2017 to 2021, pediatric depression and anxiety rates increased by 55.6% and 31.1%, respectively. Rates were higher ...

Some people living with bipolar disorder also experience major depressive episodes or “down” moods. These three main symptoms — mania, hypomania, and depression — are the main features of ...